Skip to content

Clinical trials

Leukemia trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia Country / region: Norway Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20072
20081
20092
20101
20131
20142
20161
20171
20191
20201
20211
20222
20232
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting8
Terminated3
Active, not recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Pfizer4
Princess Maxima Center for Pediatric Oncology3
Bristol-Myers Squibb2
Mats Heyman2
Aarhus University Hospital1
AbbVie1
Celgene1
Clavis Pharma1
Cogent Biosciences, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia23
Precursor Cell Lymphoblastic Leukemia-Lymphoma8
Leukemia, Myeloid, Acute7
Recurrence5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive4
Hematologic Neoplasms3
Leukemia, Myeloid3
Neoplasms3
Philadelphia Chromosome3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma3

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.